Gen-Cromoglycate Interactions
Drug Interaction During Pregnancy: Cromolyn sodium and isoproterenol were studied following
subcutaneous injections in pregnant mice. Cromolyn sodium alone in doses up to 540 mg/kg/day (approximately 340 times
the maximum recommended daily inhalation dose in adults on a mg/m2 basis) did not cause significant
increases in resorptions or major malformations. Isoproterenol alone at a dose of 2.7 mg/kg/day (approximately 7
times the maximum recommended daily inhalation dose in adults on a mg/m2 basis) increased both resorptions
and malformations. The addition of 540 mg/kg/day of cromolyn sodium (approximately 340 times the maximum recommended
daily inhalation dose in adults on a mg/m2 basis) to 2.7 mg/kg/day of isoproterenol (approximately 7 times
the maximum recommended daily inhalation dose in adults on a mg/m2 basis) appears to have increased the
incidence of both resorptions and malformations.
Gen-Cromoglycate Contraindications
Intal Inhaler is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium or other
ingredients in this preparation.
Additional information about Gen-Cromoglycate
Gen-Cromoglycate Indication: For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.
Mechanism Of Action: Gen-Cromoglycate inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. Gen-Cromoglycate also may reduce the release of inflammatory leukotrienes. Gen-Cromoglycate may act by inhibiting calcium influx.
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Cromoglicate
Synonyms: Acide Cromoglicique [Inn-French]; Acido Cromoglicico [Inn-Spanish]; Acidum Cromoglicicum [Inn-Latin]; Cromoglicic Acid; Cromoglycic Acid; Cromolyn; Cromoglycate
Where to order Cromoglicate (and Gen-Cromoglycate analogs) online:
Drug Category: Anti-Asthmatic Agents
Drug Type: Small Molecule; Approved
Other Brand Names containing Cromoglicate: Aarane;
Alercom;
Alerion;
Allergocrom;
Apo-Cromolyn;
Children's Nasalcrom;
Colimune;
Crolom;
Cromolyn Nasal Solution;
Cromoptic;
Cromovet;
Fivent;
Gastrocrom;
Gastrofrenal;
Gen-Cromoglycate;
Inostral;
Intal;
Intal Inhaler;
Intal Syncroner;
Introl;
Irtan;
Lomudal;
Lomupren;
Lomusol;
Lomuspray;
Nalcrom;
Nalcron;
Nasalcrom;
Nasmil;
Opticrom;
Opticron;
Rynacrom;
Sofro;
Vistacrom;
Vividrin;
Absorption: 1%
Toxicity (Overdose): Symptoms of overdose include cough, nasal congestion, nausea, sneezing and wheezing.
Protein Binding: Not Available
Biotransformation: Not Available
Half Life: 1.3 hours
Dosage Forms of Gen-Cromoglycate: Aerosol, metered Respiratory (inhalation)
Spray Nasal
Solution Ophthalmic
Capsule Oral
Solution Respiratory (inhalation)
Liquid Ophthalmic
Chemical IUPAC Name: 5-[3-(2-carboxy-4-oxochromen-6-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylic acid
Chemical Formula: C23H16O11
Cromoglicate on Wikipedia: http://en.wikipedia.org/wiki/Cromoglicate
Organisms Affected: Humans and other mammals